HORIZON EUROPE
Europeo
Specific Challenge:A major hurdle in reliable risk assessment and management of chemicals is the lack of harmonised information about the exposure of citizens, including workers, to chemicals and their interplay with other concurrent environmental exposures and impact on health. Each individual is today exposed to a large number of chemicals in their environment, including the workplace, through the air, food, water and consumer products. For many of the chemicals, the health impact, including long-term, is still unknown. Innovative approaches are needed to enable us to decipher the potential causal associations between exposures and health effects over a lifetime and, where such links are identified, to understand the underlying mechanisms.
A first step to better assess and understand this potential impact on heath is to gather harmonised and comparable information on population exposure to chemicals in Europe through human biomonitoring (HBM), to link this information to data on exposure sources and epidemiological surveys and to promote research on the exposure-response relationships in humans.
Scope:The objective is to create a European joint pr...
ver más
Specific Challenge:A major hurdle in reliable risk assessment and management of chemicals is the lack of harmonised information about the exposure of citizens, including workers, to chemicals and their interplay with other concurrent environmental exposures and impact on health. Each individual is today exposed to a large number of chemicals in their environment, including the workplace, through the air, food, water and consumer products. For many of the chemicals, the health impact, including long-term, is still unknown. Innovative approaches are needed to enable us to decipher the potential causal associations between exposures and health effects over a lifetime and, where such links are identified, to understand the underlying mechanisms.
A first step to better assess and understand this potential impact on heath is to gather harmonised and comparable information on population exposure to chemicals in Europe through human biomonitoring (HBM), to link this information to data on exposure sources and epidemiological surveys and to promote research on the exposure-response relationships in humans.
Scope:The objective is to create a European joint programme for monitoring and scientific assessment of human exposures to chemicals and potential health impacts in Europe, building on previous activities undertaken at EU and national levels. This European Human Biomonitoring Initiative (EHBMI) should:
be achieved through coordination of HBM initiatives at national and EU level, with a special focus on linking research to evidence-based policy making. build on European excellence in the field and promote capacity building and the spread of best practice. provide a platform through which harmonised and validated information and data collected at national level can be accessed and compared. support research and innovation in various ways, e.g., by improving underlying methods and procedures (e.g., for sampling, sample analysis, data analysis, and data management), by improving the understanding of the impact of the exposure on human health (e.g., development of validated exposure and effect biomarkers and establishing correlation between biomarker levels and health risks) and by improving the use of HBM data in risk assessment of chemicals and their mixtures. The acquired knowledge should support informed decision taking and policy making in a wide variety of sectors, one of the most important being the EU chemicals legislation under REACH[1].
The governance structure of the EHBMI should allow for review of the priority setting with regards to chemicals to be investigated by the initiative, taking into account the scientific advances at national and EU level.
The proposal should include a five-year roadmap describing the key priorities and governance processes as well as the first annual work plan.
The joint programme should be structured along three main components:
a platform providing support for field sampling and analytical work by competent national laboratories and a data infrastructure; a research programme to assess the impact of chemical exposure on human health; and an activity focused on translation of programme results into policy. The three components must operate in close coordination, in order to address the overall priorities of the initiative.
The platform on field sampling and analytical work should include joint activities aiming at advancing, harmonising and quality assurance in field work practices and analytical methods and contribute to the development of EU reference values. Potential research aspects to be addressed are, inter alia, related to developing innovative analytical methods, including in atypical biological matrices, non-invasive technologies, new biomarkers, and reference materials. A network of reference laboratories and field survey entities of high quality must be established, engaged in capacity building across Europe and facilitating access to special equipment. Best practices for management of data resulting from linking analytical results and field surveys must be established, facilitating the data inclusion into the Information Platform for Chemical Monitoring Data (IPChem platform[2]) currently under development by the EU Joint Research Centre.
The EHBMI should ensure the inclusion of new HBM data and whenever possible existing HBM data to IPChem and address outstanding issues related to HBM data policy and data quality assurance. Furthermore, the consortium should ensure that the new data, relevant for policy making, produced in this initiative, will be made available to regulators at the national and EU level. For this purpose the proposal should include a draft Data Management Plan, renewed annually, detailing what data the project will generate, how it will be used and/or made accessible for regulatory purposes.
The research programme to understand the impact of exposures on human health should include joint research on correlation, integration and analysis of data from different sources, e.g., HBM data, environmental, occupational, health examination and epidemiological surveys; research on exposure mechanisms and modes of actions and research for innovative approaches to risk assessment.
The work undertaken under the science-policy interface component should aim at informing existing policy making processes (from chemicals to health) at EU and national level about the outcome of the EHBMI, exploring the possibilities and requirements for an increased use of HBM data in evidence-based policy processes and mobilising existing committees and expert/advisory groups to contribute to setting priorities.
Research activities may be supported by open calls for proposals organised by the consortium, if deemed necessary, aiming at bringing in additional expertise and engaging with the wider research community.
Dissemination, communication and training activities should be included in the initiative, in particular efforts to increase public awareness and understanding of the obtained results and their implications for policy making and self-responsible lifestyle management. A public engagement component should be included whereby citizen science approaches to human biomonitoring are explored and sought.
The minimum number of participants is five independent legal entities from different Member States or associated countries owning or managing national research and innovation programmes. In addition to the minimum conditions, other legal entities may participate if justified by the nature of the action.
Horizon 2020 contribution will be limited to a maximum of 70% of the total eligible costs of the action with a maximum of EUR 50 million of EU contribution for the expected five years duration of the action.
The Commission will only fund one proposal under this topic.
Expected Impact: Coordinating HBM initiatives in Europe at national and EU level and spreading of best practice and capacity building. Advancing the understanding of the nature and level of chemical exposure of EU citizens at all ages, including workers, and the potential health risks leading to better protection of the health of EU citizens. Gender aspects should be taken into account where relevant. Establishing a strong EU-wide evidence base of comparable and validated exposure and health data for sound policy-making at EU and national level, based on evidence-based regulation, risk assessment and management, whilst striking an appropriate balance with industrial competitiveness. Preparation for a possible public-public partnership under Article 185 of the Treaty.
Cross-cutting Priorities:GenderSocio-economic science and humanities
[1]http://echa.europa.eu/regulations/reach
[2]IPChem aims to support a coordinated approach to collecting, storing and accessing monitoring data on chemicals and chemical mixtures in humans and in the environment: http://ipchem.jrc.ec.europa.eu/#home-page
ver menos
Características del consorcio
:
La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Características del Proyecto
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Características de la financiación
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
Evaluation
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
European J... Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
Evaluation
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
European Joint Programme (EJP) Cofund
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
H2020 MGA EJP Cofund – Multi-Beneficiary
Annotated Grant Agreement
Additional provisions:
Horizon 2020 budget flexibility
Classified information
Financial support to Third Parties – where a topic description foresees financial support to Third Parties, these provisions apply.
Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Additional documents:
H2020 Work Programme 2016-17: Health, demographic change and wellbeing
H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation
H2020 Work Programme 2016-17: General Annexes
Legal basis: Horizon 2020 - Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
Información adicional de la convocatoria
Otras ventajas
Ayudas Similares
| Abierta
| Próximamente
| Abierta